home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

195.51 -2.64 (-1.33%)

Official Closing Price Updated: 7:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

UiPath is a Cheaper and More Profitable AI Stock

April 06, 2023

With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest

Via MarketBeat

Topics Artificial Intelligence

Analyst Expectations for Quest Diagnostics's Future ↗

April 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗

April 03, 2023

Via Benzinga

Analyst Expectations for Quest Diagnostics's Future ↗

March 17, 2023

Via Benzinga

5 Analysts Have This to Say About Quest Diagnostics ↗

January 23, 2023

Via Benzinga

Analyst Ratings for Quest Diagnostics ↗

January 06, 2023

Via Benzinga

Where Quest Diagnostics Stands With Analysts ↗

December 14, 2022

Via Benzinga

Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session

March 24, 2023

Via Investor Brand Network

Is This Healthcare Stock a Buy for Dividend Growth Investors? ↗

March 07, 2023

This maker of diagnostics tests just announced that it will be sending more cash to its shareholders.

Via The Motley Fool

2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7% ↗

February 15, 2023

These companies may not be finished raising their dividend payments as they both have low payout ratios.

Via The Motley Fool

Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗

January 23, 2023

Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.

Via The Motley Fool

These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades' ↗

December 23, 2022

On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5%

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Golden Cross Appears Before Quest Diagnostics Investors ↗

November 28, 2022

Via Benzinga

Where Quest Diagnostics Stands With Analysts ↗

November 17, 2022

Via Benzinga

Why Quest Diagnostics Stock Jumped Today ↗

October 20, 2022

Growth in the lab testing titan's core business is accelerating.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 ↗

January 23, 2023

Via Benzinga

Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday ↗

November 17, 2022

Via Benzinga

Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance ↗

October 20, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test

November 15, 2022

From DermTech, Inc.

Via Business Wire

Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio

October 31, 2022

Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.

Via MarketBeat

Quest Diagnostics: Q3 Earnings Insights ↗

October 20, 2022

Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Via Benzinga

A Preview Of Quest Diagnostics's Earnings ↗

October 19, 2022

Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Quest...

Via Benzinga

Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade ↗

October 03, 2022

On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b

Via Benzinga

What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day ↗

September 30, 2022

CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined...

Via Benzinga

Earnings Scheduled For October 20, 2022 ↗

October 20, 2022

Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion.

Via Benzinga

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards

September 14, 2022

From Achievers

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com